Custom API Manufacturing Solutions
From Development to Commercial Scale Production
In the pharmaceutical industry, the quality and reliability of your Active Pharmaceutical Ingredient (API) can determine the success or failure of your entire drug development program. ApiSyn, an emerging CDMO (Contract Development & Manufacturing Organization), specializes in providing comprehensive API development and manufacturing services for complex, niche, and small molecules. As a subsidiary of SynZeal Research, ApiSyn combines cutting-edge R&D capabilities with cGMP-compliant manufacturing infrastructure to deliver solutions that meet the most demanding global regulatory standards.
Whether you're in early-stage development or preparing for commercial launch, ApiSyn's CDMO services provide the expertise, flexibility, and quality assurance your API program demands.
Why Choose a CDMO Partner for Your API Development?
Contract Development and Manufacturing Organizations (CDMOs) have become essential partners in the modern pharmaceutical industry. Rather than building and maintaining expensive in-house manufacturing facilities, companies can leverage a CDMO's existing infrastructure, expertise, and regulatory approvals to accelerate their drug development programs and reduce capital expenditure.
What is a CDMO?
A CDMO provides both development and manufacturing services—including process R&D, scale-up, analytical development, and regulatory support. Unlike a Contract Manufacturing Organization (CMO), which typically handles manufacturing of established processes, a CDMO works with you from the earliest development stage through to commercial supply.
ApiSyn's CDMO Advantage:
ApiSyn is a full-service CDMO equipped with a 2,10,476 sq. ft. R&D campus, state-of-the-art laboratory facilities, and experienced process chemists who can handle complex chemistry challenges that many competitors cannot. Our team specializes in small molecule synthesis, custom intermediates, peptides, amino acids, and advanced chemical synthesis for pharmaceutical applications.
ApiSyn's Comprehensive API Development Services
1. Process Route Scouting & Optimization
Every API has multiple synthesis pathways. ApiSyn's process chemistry team evaluates route options to identify the most cost-effective, scalable, and environmentally sustainable approach for your molecule. This early-stage work is critical for:
- Reducing manufacturing costs
- Improving yield and purity
- Minimizing waste and environmental impact
- Accelerating path to IND and clinical development
ApiSyn Advantage:Our process development team has expertise in multistep organic synthesis, complex chemistry, and sustainable manufacturing methods. We deliver robust, scalable routes optimized for your target market and timeline.
2. cGMP Clinical Manufacturing
Manufacturing API for clinical trials requires strict adherence to current Good Manufacturing Practices (cGMP) while maintaining flexibility to accommodate evolving trial requirements. ApiSyn's clinical manufacturing capabilities support IND applications and phases I-III trials with dedicated equipment and qualified personnel.
3. Analytical Development & Characterization
Quality by Design (QbD) is essential in modern pharmaceutical development. Our analytical team develops and validates methods for:
- Identity testing (HPLC, GC, LC-MS, NMR)
- Purity assessment and impurity profiling
- Physicochemical characterization
- Stability testing and degradation profiling
- Reference standard development
ApiSyn Advantage:In partnership with SynZeal Research, ApiSyn can supply custom impurity standards and reference materials to support your analytical validation, ensuring seamless method development.
4. Scale-Up & Commercial Manufacturing
Once your process is optimized and clinical data supports commercialization, ApiSyn scales your API production from pilot to multi-ton commercial batches while maintaining strict regulatory compliance and consistent quality.
ApiSyn's Manufacturing Capabilities
✓ Small Molecule Synthesis
Complex multistep organic synthesis for novel and generic APIs across multiple therapeutic areas.
✓ Peptides & Amino Acids
Specialized peptide synthesis and amino acid custom manufacturing with stringent purity specifications.
✓ Advanced Intermediates
Custom synthesis of pharmaceutical intermediates for complex API programs and unique chemistries.
✓ Regulatory Support
Full CMC documentation, regulatory filings, and FDA/EMA compliance support for your API program.
Why Pharma Companies Choose ApiSyn as Their CDMO Partner
1. SynZeal Heritage & Expertise
As a subsidiary of SynZeal Research (established 2011, ISO 9001:2015 & ISO 17034 certified), ApiSyn brings over a decade of pharmaceutical innovation and regulatory excellence to every project.
2. State-of-the-Art Facilities
Our 2,10,476 sq. ft. R&D campus is equipped with modern laboratory infrastructure, analytical instruments, and manufacturing units designed for flexibility and scalability.
3. Regulatory Approvals & Compliance
ApiSyn maintains cGMP certifications and operates under stringent quality assurance protocols aligned with FDA, EMA, and ICH guidelines for pharmaceutical manufacturing.
4. End-to-End Solutions
From initial route scouting through commercial launch, ApiSyn provides integrated services that eliminate the need for multiple vendors and reduce your project complexity.
5. Cost-Competitive Indian Manufacturing
Located in Ahmedabad, India's pharmaceutical hub, ApiSyn offers significant cost advantages without compromising on quality or regulatory acceptance globally.
6. Access to SynZeal's Reference Standards
Leverage SynZeal's extensive portfolio of pharmaceutical reference standards and impurity compounds to support your analytical development and method validation.
Need a Trusted CDMO Partner for Your API Program?
Whether you're developing a novel drug or manufacturing a complex generic API, ApiSyn delivers the expertise, quality, and reliability you need.
Explore ApiSyn's Services
The API CDMO Landscape: How ApiSyn Stands Out
The CDMO market has grown exponentially as pharmaceutical companies recognize the strategic value of outsourcing API manufacturing. However, not all CDMOs are created equal. Key differentiators include:
- Expertise in Complex Chemistry: Ability to handle challenging synthetic routes, high-potency APIs, and niche molecules
- Regulatory History: Track record of successful regulatory filings and FDA/EMA approvals
- Quality Infrastructure: Certified facilities, analytical capabilities, and quality assurance systems
- Flexibility & Responsiveness: Ability to adapt to timeline changes and evolving project requirements
- Cost Efficiency: Competitive pricing without compromising quality or compliance
ApiSyn excels in all these areas, combining the innovation-driven culture of SynZeal Research with the operational efficiency of a lean, focused CDMO team.
From IND to Commercial: ApiSyn's Project Timeline
The timeline for bringing an API from concept to commercial supply depends on many factors—compound complexity, regulatory pathway, production volume, and market requirements. ApiSyn's integrated approach accelerates this journey:
- Route Development: 3-6 months (depending on complexity)
- Clinical Manufacturing: 6-12 months for IND and Phase I/II/III support
- Scale-Up & Tech Transfer: 6-18 months for commercial preparation
- Commercial Supply: Long-term partnership for ongoing batch manufacturing
The success of your drug development program depends on choosing the right CDMO partner. ApiSyn, backed by the SynZeal Research legacy, provides the expertise, infrastructure, and quality assurance needed to navigate the complex journey from API concept to commercial manufacturing. With a commitment to innovation, regulatory excellence, and customer success, ApiSyn is the trusted CDMO partner your pharmaceutical program deserves.
Ready to accelerate your API development program? Contact ApiSyn today to discuss your API development and manufacturing requirements.